# Thymus Transplantation Dose in DiGeorge #932

> **NCT00576836** · PHASE2 · COMPLETED · sponsor: **Sumitomo Pharma Switzerland GmbH** · enrollment: 7 (actual)

## Conditions studied

- DiGeorge Anomaly
- DiGeorge Syndrome
- Complete DiGeorge Anomaly
- Complete DiGeorge Syndrome

## Interventions

- **BIOLOGICAL:** Cultured Thymus Tissue Implantation (CTTI)
- **OTHER:** Cultured Thymus Tissue Implantation with Parathyroid Transplantation

## Key facts

- **NCT ID:** NCT00576836
- **Lead sponsor:** Sumitomo Pharma Switzerland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09-02
- **Primary completion:** 2010-11
- **Final completion:** 2019-12-31
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2022-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00576836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00576836, "Thymus Transplantation Dose in DiGeorge #932". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00576836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*